Northwestern’s Cancer Survivorship Institute addresses the medical, psychological and social challenges patients face after their cancer is gone.
Author: nld552
Northwestern investigators want to know why some people are immune to age-related cognitive decline. Their answers could inform future therapies for neurodegenerative diseases like Alzheimer’s.
Northwestern Medicine scientists are exploring a new drug that could make people healthier for longer by slowing the aging process.
Through pioneering research in oncofertility, reproductive endocrinologist Teresa Woodruff, PhD, offers young cancer survivors options to have children.
Feinberg’s PhD in healthcare quality and patient safety program aims to prevent 440,000 deaths each year in the United States caused by medical errors.
A Northwestern research team has developed a first-of-its-kind flexible microfluidic device that adheres to the skin and measures the wearer’s sweat.
A pair of proteins that promote blood vessel formation are associated with the development of severe malaria, and they may be a target for future therapeutics, according to recent research.
Internationally renowned Swiss neuro-oncologist Roger Stupp, MD, will join Northwestern Medicine as a professor of Neurological Surgery.
Ronald Ackermann, MD, MPH, has been named senior associate dean for public health and director of the Institute for Public Health and Medicine (IPHAM), succeeding IPHAM’s inaugural leader, Rowland Chang, MD, MPH.
A 3-D printable ink developed by Northwestern scientists produces synthetic bone implants with unique properties to induce bone regeneration.